The fact that Si has stated that one of the problems was that later stage patients were 10-15 years older and loaded with experimental drugs... When he originally had been trumpeting that the product is targeted toward the sickest of the sick who've not responded to all other treatment is a complete 360 turnaround and is another indication that SI has no clue about MOA.
This is an embarrassment and he should stand down from his post as CEO.
The fact that Si has stated that one of the problems was that...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22000 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 36989 | 4 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |